Form4insider filings, from the source

SEC Form 4 · accession 0000899243-16-035219

Coherus Oncology, Inc. · CHRS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Dec 7, 2016
Accepted (ET)
Dec 9, 2016 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001512762

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, $0.0001 par valueF1,F2Dec 7, 2016S7,393$27.503D46,190ISee Footnote
Common Stock, $0.0001 par valueF3,F2Dec 8, 2016S46,190$27.5243D0ISee Footnote
Common Stock, $0.0001 par valueF4holding———578,528ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses